CNAM
EGRX

Campbell Newman Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Campbell Newman Asset Management’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,614
Closed -$494K – 125
2020
Q4 		$494K Buy
10,614
+793
+8% +$37.1K 0.06% 108
2020
Q3 		$417K Buy
9,821
+177
+2% +$7.74K 0.05% 109
2020
Q2 		$463K Buy
9,644
+95
+1% +$4.74K 0.06% 101
2020
Q1 		$439K Sell
9,549
-458
-5% -$23K 0.08% 94
2019
Q4 		$601K Sell
10,007
-20
-0.2% -$1.19K 0.08% 97
2019
Q3 		$567K Sell
10,027
-81
-0.8% -$4.55K 0.08% 100
2019
Q2 		$563K Buy
10,108
+671
+7% +$35K 0.08% 102
2019
Q1 		$476K Buy
9,437
+234
+3% +$10.4K 0.07% 108
2018
Q4 		$371K Buy
9,203
+965
+12% +$49.7K 0.06% 109
2018
Q3 		$571K Buy
8,238
+430
+6% +$32.6K 0.08% 97
2018
Q2 		$591K Buy
7,808
+3,854
+97% +$242K 0.09% 92
2018
Q1 		$208K Buy
3,954
+202
+5% +$11.7K 0.03% 127
2017
Q4 		$200K Buy
+3,752
New +$209K 0.03% 128
2017
Q3 		– Sell
-2,693
Closed -$212K – 131
2017
Q2 		$212K Buy
2,693
+126
+5% +$10.3K 0.04% 123
2017
Q1 		$213K Buy
+2,567
New +$191K 0.04% 116

Other funds holding EGRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SGCIA
Smith Graham & Co Investment Advisors Houston, Texas $868M AUM 24.69% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Campbell Newman Asset Management's EGRX Position: Q1 2021 in Review

Campbell Newman Asset Management sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q1 2021, closing a stake of 10,614 shares — an estimated $494K sold.

Campbell Newman Asset Management first reported a position in EGRX in Q1 2017 and held it in 15 quarters. The position peaked at $601K in Q4 2019. 155 funds tracked by Wall St. Rank hold EGRX as of Q1 2021.

  • Campbell Newman Asset Management reported no remaining Eagle Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
  • Campbell Newman Asset Management sold 10,614 Eagle Pharmaceuticals, Inc. shares in Q1 2021, an estimated $494K.
  • Campbell Newman Asset Management first reported a position in Eagle Pharmaceuticals, Inc. in Q1 2017 and held it in 15 quarters.
  • Campbell Newman Asset Management's Eagle Pharmaceuticals, Inc. position peaked at $601K in Q4 2019.
  • 155 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q1 2021.

Based on Campbell Newman Asset Management's 13F filing for Q1 2021, filed 19 Apr 2021.